NT Pro-Brain Natriuretic Peptide(Recombinant)

Added to your cart

NT Pro-Brain Natriuretic Peptide(Recombinant)

Cart subtotal: £0.00

View cart (0) Checkout

#SKU P305-1

£3695.32

Price excludes shipping costs.
To view our shipping costs click here.

Need to order this product in bulk?

Contact our team of experts to discuss your bulk requirements

Contact our expert team

Product Details

The Natriuretic peptide family of hormones are secreted primarily from the heart, kidneys and brain that cause vasodilation and natriuresis.proBNP is cleaved on secretion into the bloodstream to produce the two biomarkers of 32-aa BNP and 76-aa NT-proBNP. NT ProBNP has a longer half-life than BNP in serum making it a preferable biomarker. BNP and NT-proBNP are released from cardiac myocytes in response to mechanical load and wall stress. Elevated levels of BNP and NT-proBNP are helpful to aid diagnosis of systemic sclerosis.
1mg
P305-1

More information

Attributes

Description

  • Shipping Information
  • Dry Ice
  • Abbreviations
  • NT-ProBNP
  • Specification
  • >95%
  • Recommended Use
  • Research and further manufacturing
  • Storage
  • Below -15°C
  • Buffer
  • lyophilised from ammonium acetate buffer, pH 7.0
  • Presentation Matrix
  • lyophilised from ammonium acetate buffer, pH 7.0. May contain traces of buffer salts
  • Purity/grade
  • >95%
  • Source
  • Expressed in E.coli
  • Applications
  • Biosensors, Clinical Chemistry, Control Manufacture, ELISA, Lateral Flow, Life Science
  • Molecular weight
  • 7.4-8.4kDa

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox